Shares of Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH) witnessed a significant surge of over 10% in after-hours trading, driven by the company's announcement of initiating an exploration of strategic alternatives.

The Board of Aurinia will carefully assess various options, including but not limited to a potential sale, merger, or other strategic transactions. However, it is important to note that the outcome of this process is uncertain, and there is no guarantee that a specific transaction or strategic outcome will be pursued.

Meanwhile, shares of Root, Inc. (Nasdaq: ROOT) experienced a sharp decline of more than 15.00% during the extended session. The company clarified that, as of now, there have been no actionable proposals or proposals in the best interests of Root's shareholders.

Last week, rumors and media reports had suggested the possibility of Root being acquired.

In after-hours trading, $AUPH was trading at $10.15, reflecting a notable increase of $0.99 (10.81%) following the announcement. Conversely, $ROOT was trading at $9.37, indicating a decline of $1.84 (-16.41%) in after-hours.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)